Mankind Pharma IPO

Mankind Pharma IPO Review, Date, Price, GMP, Allotment

Mankind Pharma Limited, founded in 1991, is a prominent pharmaceutical company that specializes in manufacturing and marketing various pharmaceutical formulations in several acute and chronic therapeutic areas, as well as several consumer healthcare products.

In India, the company has a significant presence in a variety of acute and chronic therapeutic fields, such as anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.

Mankind Pharma’s Product Line

Mankind Pharma offers a broad range of products, like prescription drugs, over-the-counter drugs, and medical devices. The company’s product line includes medicines for cardiovascular diseases, central nervous system disorders, gastroenterology, and anti-infective drugs. Some of the company’s top-selling products include:

  • Manforce: A leading brand of condoms
  • Aciloc: A medication used to treat acid reflux and stomach ulcers
  • Metrogyl: An antibiotic used to treat infections caused by bacteria and parasites
  • Zerodol: A pain-relieving medication used to treat acute pain and inflammation
  • Pregaba: A medication used to treat nerve pain caused by diabetes and shingles
  • Gas-O-Fast: A range of antacid products that help relieve digestive issues
  • Prega News: It is a pregnancy detection kit manufactured by Mankind Pharma

Mankind Pharma’s Growth and Expansion

Over the years, Mankind Pharma has expanded its operations to other countries and established its presence in the global pharmaceutical market. The company has a notable presence in the countries like United States, Europe, Asia, Africa, and the Middle East.

Mankind Pharma has also been investing in research and development to develop innovative medicines that cater to the needs of the global market. The company has established research and development centers in India and the United Kingdom, where it focuses on developing novel drug delivery systems, new chemical entities, and biosimilars.

Mankind Pharma’s Awards and Accolades

  • The Best of Bharat Awards 2022 by exchange4media 2022
  • Silver Medal from the National Awards for Manufacturing Competitiveness Assessment 2021 by International Research Institute for Manufacturing
  • Silver Award for Good Health Brand at IHW Awards 2021 in 2021
  • Best Condom Brand of the Year award at Sex Brand Awards
  • Pharma OTC Company of the Year Award at Pharma Excellence Awards 2018
  • Award for Best Design in Healthcare at Healthcare Leadership Awards 2017
  • Amity HR Excellence Award for Performance Management at the 8th Global HR Summit in 2011

Competitors of Mankind Pharma

Mankind Pharma faces stiff competition from other leading pharmaceutical companies such as Sun Pharma, Dr. Reddy’s Laboratories, Cipla, and Lupin.

Mankind Pharma IPO Complete Details:

IPO Date25 April 2023 to 27 April 2023
Issue TypeFixed Price Issue
Listing AtBSE & NSE
Face Value1Rs. Per Share
PriceRs. 1026 to 1080
Lot Size13
 Issue Size40,058,844 shares (Rs.4,326.3 Cr)
Fresh Issue40,058,844 shares (Rs.4,326.36 Cr)
Listing Date08 May 2023

Mankind Pharma IPO Timetable:

Opening Date25 April 2023
Closing Date27 April 2023
Allotment03 May 2023
Initiation of Refunds04 May 2023
Credit of Shares to Demat Account05 May 2023
Listing Date08 May 2023
* Date May Change

Company Financial Details:

Period EndedAssetsRevenueProfit After TaxBorrowingsReserves and Surplus
31 March 20205,073.295,975.651,056.15126.923,436.34
31 March 20216,372.636,385.381,293.03234.534,674.39
31 March 20229,147.747,977.581,452.96868.036,106.06
Amount In Crores

As Of Now, GMP is Around 105 Rupees.

Also, Check Our Web Story On Mankind Pharma IPO:

Leave a Reply

Your email address will not be published. Required fields are marked *